Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.29
Price to sales ratio
-439.06

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4789
APUS
Apimeds Pharmaceuticals US, Inc. Common Stock
0.74 USD0.00%-1.33%-42.19%-43.51%11.17 M USD
4875
KAPA
Kairos Pharma, Ltd. Common Stock
0.36 USD+5.88%-2.70%-20.00%-37.93%7.71 M USD
5060
DCOY
Decoy Therapeutics Inc. - Common Stock
5.75 USD-1.54%-12.61%-8.87%+610.93%3.06 M USD
5091
VIVS
VivoSim Labs, Inc. - Common Stock
0.83 USD+2.47%-8.79%-30.25%-56.54%2.16 M USD

Frequently asked questions about Propanc Biopharma, Inc. - Common Stock

What is the Propanc Biopharma, Inc. - Common Stock stock price today?

The current price of Propanc Biopharma, Inc. - Common Stock (PPCB) is 1.63. Over the past 24 hours, the stock has changed by +1.87%. Follow the PPCB chart for real-time price dynamics.

What is the stock ticker of Propanc Biopharma, Inc. - Common Stock?

Propanc Biopharma, Inc. - Common Stock trades under the ticker PPCB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Propanc Biopharma, Inc. - Common Stock stock going up?

PPCB has changed by -7.91% over the last week, -25.23% over the last month, and -59.25% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Propanc Biopharma, Inc. - Common Stock net income for the last quarter?

Propanc Biopharma, Inc. - Common Stock reported net income of -6.36 M for the last quarter. The previous quarter showed -3.09 M, which means net income changed by -105.74%.

How many employees does Propanc Biopharma, Inc. - Common Stock have?

As of the latest available data, Propanc Biopharma, Inc. - Common Stock has 2 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Propanc Biopharma, Inc. - Common Stock stock?

You can buy Propanc Biopharma, Inc. - Common Stock (PPCB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Propanc Biopharma, Inc. - Common Stock stock?

Investing in Propanc Biopharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PPCB chart and related analysis on metatrader.com as part of your research.